Dr. Frederick M. Fellin, MD

Dr. Fellin practices at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania, part of Thomas Jefferson University.

Dr. Fellin's NPI, 1679684476, was assigned on August 31, 2006. Dr. Fellin graduated from Sidney Kimmel Medical College in 1979. Dr. Fellin holds Pennsylvania license MD025210E.

Dr. Fellin's primary practice is Thomas Jefferson University Hospital, at 111 South 11th Street, Philadelphia, PA 19107 in Philadelphia County. The practice phone is (215) 955-6000.

Dr. Fellin's primary practice is Thomas Jefferson University Hospital in Philadelphia, Pennsylvania, part of Thomas Jefferson University. Dr. Fellin is also affiliated with Jefferson Abington Hospital. The medical group on file is Jefferson University Physicians. Dmand AI also links Dr. Fellin to 2 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fellin practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Fellin's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Fellin is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Fellin's licenses on file in 3 states: Pennsylvania, Delaware and New Jersey.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, immune deficiency disease, lung cancer and lymphoma among the conditions Dr. Fellin treats.

CMS data shows 624 Medicare services from Dr. Fellin across 10 procedure codes in 2024, for 294 Medicare patients. Medicare paid $44,327 for them.

CMS counts 294 Medicare patients who saw Dr. Fellin in 2024. The largest group is 65 to 74, with 128 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fellin's median patient age at 73, with 70% women.

In 2024, Dr. Fellin wrote 757 Medicare Part D claims for 168 patients. 68% of them were for generic drugs. CMS names the drug for 588 of them, across 20 drugs with 11 or more claims each, at $3,164,350 in total drug cost. In 2023, CMS named 649 claims across 22 drugs.

Dr. Fellin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Fellin as offering telehealth.

Dmand AI links 13 papers to Dr. Fellin, published from 2018 to 2022. The most frequent topics are Breast Neoplasms, Liver and Rabbits. Dr. Fellin has published most often in J Biol Chem. Dr. Fellin's most frequent co-authors are Maysa M. Abu-Khalaf, MD, Rebecca Jaslow, MD and Saveri Bhattacharya, DO.

Dmand AI links Dr. Fellin to 4 clinical trials, 2 of them phase 2 studies. Conditions studied include Breast Neoplasms, Breast Neoplasms, Male and Triple Negative Breast Neoplasms. Sidney Kimmel Cancer Center at Thomas Jefferson University sponsors the most, 2.

CMS Open Payments shows 4 general payments to Dr. Fellin from 3 drug and device companies from 2017 to 2023. Food and beverage make up the largest share, 91% of the total. Kite Pharma, Inc. paid the most, $66.

Dmand AI lists 4 awards for Dr. Fellin, most recently NCQA PCSP in 2017.

Dr. Fellin graduated from Sidney Kimmel Medical College in 1979. Dr. Fellin is a member of ACP, AMA, ASCO and ASH.

Dr. Fellin is in network with 15 carriers, including Aetna, Highmark and United Healthcare. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.